SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-002040
Filing Date
2019-02-06
Accepted
2019-02-05 18:36:54
Documents
98
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q-20181231 mygn-10q_20181231.htm 10-Q 3009101
2 EX-31.1 mygn-ex311_7.htm EX-31.1 15856
3 EX-31.2 mygn-ex312_10.htm EX-31.2 16326
4 EX-32.1 mygn-ex321_9.htm EX-32.1 6532
  Complete submission text file 0001564590-19-002040.txt   12942500

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mygn-20181231.xml EX-101.INS 3717444
6 XBRL TAXONOMY EXTENSION SCHEMA mygn-20181231.xsd EX-101.SCH 65447
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20181231_cal.xml EX-101.CAL 75589
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20181231_def.xml EX-101.DEF 212324
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20181231_lab.xml EX-101.LAB 472216
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20181231_pre.xml EX-101.PRE 389160
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 19569320
SIC: 2835 In Vitro & In Vivo Diagnostic Substances